Literature DB >> 17391696

Identification of a novel isoform of iASPP and its interaction with p53.

Xinwei Zhang1, Shiyong Diao, Qing Rao, Haiyan Xing, Hang Liu, Xiaolong Liao, Min Wang, Jianxiang Wang.   

Abstract

iASPP is an inhibitory member of ASPP (apoptosis stimulating protein of p53, or Ankyrin repeats, SH3 domain and proline-rich region contain Protein) family. As reported previously, it at least includes two isoforms, one is iASPP/RAI (351 amino acids, aa) and the other is iASPP (828 aa).Here, we identified a novel open reading frame of human iASPP, which encodes a 407 aa protein and highly matches with the C terminus of iASPP (828 aa, CAI60219). Hereafter, iASPP (407 aa) will be referred to as iASPP-SV (iASPP splice variant). In further study, we found that iASPP-SV is a nuclear protein, and is capable of binding to p53 in vivo. Moreover, overexpression of iASPP-SV can inhibit the transcriptional activity of p53 on the promoters of both Bax and p21.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391696     DOI: 10.1016/j.jmb.2007.03.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

1.  A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.

Authors:  Crystal Woodard; Gangling Liao; C Rory Goodwin; Jianfei Hu; Zhi Xie; Thaila F Dos Reis; Rob Newman; Heesool Rho; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

2.  Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.

Authors:  Xiangrong Liu; Jun Kang; Fang Liu; Shaohong Wen; Xianwei Zeng; Kuan Liu; Yumin Luo; Xunming Ji; Shangfeng Zhao
Journal:  Tumour Biol       Date:  2015-12-01

3.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.

Authors:  Jinfeng Chen; Fei Xie; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2010-12-30       Impact factor: 4.430

4.  Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.

Authors:  Shaowei Qiu; Shuang Liu; Tengteng Yu; Jing Yu; Min Wang; Qing Rao; Haiyan Xing; Kejing Tang; Yinchang Mi; Jianxiang Wang
Journal:  BMC Cancer       Date:  2017-11-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.